At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of Software Enhancements to the Respironics BiPAP autoSV Device
In Brief
A clinical study evaluating Respironics BiPAP autoSV2 and Respironics BiPAP autoSV3 for Sleep Disordered Breathing and Sleep Apnea, Central. Completed, enrolled 44 participants across 5 sites.
Detailed Summary
This study is being undertaken to collect data from Respironics Inc's BiPAP Auto Servo Ventilation 3 (autoSV3) and compare with data from Respironics, Inc's BiPAP autoSV2, to confirm that the algorithms in the BiPAP autoSV3 device can safely and effectively treat participants experiencing Complex Sleep Apneas (Comp SAS) no worse than its predecessor, the BiPAP auto Servo ventilation 2 (autoSV2) device. This will be determined using a comparative, randomized design with the participants blinded to the therapy. Additionally, attempts will be made to blind the central scorer(s) with respect to which device is in use.
Study Details
Timeline
Interventions
Respironics BiPAP autoSV2 is an Auto Servo Ventilation Device. This will be used on a randomized night.
Respironics BiPAP autoSV3 is an Auto Servo Ventilation Device. This will be used on a randomized night.